According to ANI Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 18,883,000. At the end of 2023 the company had 18,883,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 18.88 M | 15.67% |
2022 | 16.32 M | 15.22% |
2021 | 14.16 M | 18.11% |
2020 | 11.99 M | 0.93% |
2019 | 11.88 M | 1.33% |
2018 | 11.73 M | 1.53% |
2017 | 11.55 M | 0.77% |
2016 | 11.46 M | 0.37% |
2015 | 11.42 M | 1.2% |
2014 | 11.28 M | 18.74% |
2013 | 9.5 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novartis NVS | 2,044,000,000 | 10,724.55% | ๐จ๐ญ Switzerland |
Pfizer PFE | 5,647,000,000 | 29,805.21% | ๐บ๐ธ USA |
Cardinal Health CAH | 245,000,000 | 1,197.46% | ๐บ๐ธ USA |
Jazz Pharmaceuticals JAZZ | 62,578,000 | 231.40% | ๐ฎ๐ช Ireland |
Evoke Pharma
EVOK | 3,343,070 | -82.30% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | 47,261,000 | 150.28% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 5,836.56% | ๐ฎ๐ฑ Israel |
Royalty Pharma RPRX | 448,439,000 | 2,274.83% | ๐ฌ๐ง UK |
Lannett Company LCI | 10,311,428 | -45.39% | ๐บ๐ธ USA |